{
  "docId": "019de077-0326-7579-845c-ff13347b3147",
  "docSlug": "a6759fd47798a8f3f6e744ad8917865e",
  "documentTitle": "Exscientia | Investor Presentation Deck | 93 slides",
  "authorId": "exscientia",
  "authorName": "Exscientia",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 59,
  "pageCount": 93,
  "prevPage": 58,
  "nextPage": 60,
  "slideType": "traction",
  "function": "show_traction",
  "density": "dense",
  "nDataPoints": 5,
  "notes": "The chart compares % Reduction PLN Weight across different doses of EXS4318 versus a failed competitor drug.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de077-0326-7579-845c-ff13347b3147/59",
  "deckHref": "/decks/019de077-0326-7579-845c-ff13347b3147",
  "deckJsonHref": "/decks/019de077-0326-7579-845c-ff13347b3147.json",
  "deckAnchorHref": "/decks/019de077-0326-7579-845c-ff13347b3147#slide-59",
  "components": [
    {
      "bbox": {
        "h": 0.6,
        "w": 0.45,
        "x": 0.07,
        "y": 0.235
      },
      "kind": "chart",
      "text": "Better Efficacy at Approximately Half the Dose",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "98d5d7f2-24b7-493f-8d30-b4ef1baaa46c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.4,
        "x": 0.55,
        "y": 0.6
      },
      "kind": "list",
      "text": "Key Elements of TPP: 24 hrs coverage of IC80 required to drive efficacy; Predicted human dose <200 mg/day; High demands on target potency, selectivity, pharmacokinetics; Robust translation into cellular and human whole blood assays",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6dfe73bd-f02d-4808-acb0-2cebd051ac72",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.4,
        "x": 0.55,
        "y": 0.24
      },
      "kind": "list",
      "text": "Potential First-in-class Immunology Asset: High-value immunology target that had eluded many large biopharmas due to selectivity challenges; Balanced profile provided improvements in human whole blood potency and predicted human dose <200 mg/day; Excellent selectivity versus near neighbours and broad kinome",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "967e9020-d9e9-44a3-9ece-cd231fac16f4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.6,
        "x": 0.07,
        "y": 0.14
      },
      "kind": "title",
      "text": "Expert led AI-design to deliver against a high-value target",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d86be853-4a1a-467f-adbb-b4b020ebfd05",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.07,
        "y": 0.07
      },
      "kind": "title",
      "text": "PKC-theta: In-licensed by BMY in August 2021",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e9fbe63b-02fe-48f4-bf82-639b5afd0092",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "AIDA Model",
      "slug": "aida-model",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "23e56f45-2c50-4814-bfbf-d2604a03c4a6",
      "evidence": "The slide components include a list of bullet points that highlight the key elements of a target product profile (TPP), which aligns with the AIDA model's attention-grabbing and interest-generating structure.",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 76,
      "from": 40,
      "beatId": "5ac1e19c-a020-4b03-85c5-f8d4af660d2d",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Traction",
      "beatSlug": null,
      "evidence": "Highlighting of Exscientia's achievements and partnerships",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}